- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.03. | Mobile-health Network Solutions files to sell 3.34M Class A ordinary shares | 1 | Seeking Alpha | ||
| 21.03. | Mobile-health Network Solutions - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 06.03. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | Centurion One Capital Corp.: Mobile-health Network Solutions to Present at Centurion One Capital 8th Annual Growth Conference | 222 | Newsfile | Singapore, Singapore--(Newsfile Corp. - February 27, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a pioneering MedTech company dedicated to enhancing human connection... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 19.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 04.02. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.01. | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 26.12.24 | Mobile-health Network Solutions - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 17.12.24 | Mobile-health Network Solutions Launches ManaSocial, New Digital Healthcare Engagement Platform Expected to Accelerate Growth | 3 | GlobeNewswire (USA) | ||
| 23.10.24 | Mobile-health Network Solutions Reports 77 Percent Revenue Increase for Fiscal Year 2024 | 245 | GlobeNewswire (Europe) | SINGAPORE, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the fiscal... ► Artikel lesen | |
| 23.10.24 | Mobile-health Network Solutions - 20-F, Annual and transition report of foreign private issuers | 2 | SEC Filings | ||
| 15.10.24 | Mobile-health Network Solutions Announces Participation in the LD Micro Main Event XVII | 252 | Newsfile | Singapore, Singapore--(Newsfile Corp. - October 15, 2024) - Mobile-health Network Solutions (NASDAQ: MNDR), a leading Asia-Pacific telehealth provider, announced today that it will be presenting at... ► Artikel lesen | |
| 21.09.24 | Mobile-health Network Solutions Delinquency Notification Letter From Nasdaq | 325 | GlobeNewswire (Europe) | SINGAPORE, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that it received... ► Artikel lesen | |
| 19.06.24 | Mobile-health Network Solutions Pte Ltd: Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day | 536 | JCN Newswire | SINGAPORE, June 19, 2024 - (NewMediaWire) - Mobile-health Network Solutions ['MaNaDr'](Nasdaq: MNDR), a leading Asia-Pacific telehealth provider, today announced updated pricing for its medical weight... ► Artikel lesen | |
| 21.05.24 | Mobile-health Network Solutions Revenue Rises Approximately 120% in the First Six Months of Fiscal 2024 | 291 | GlobeNewswire (Europe) | SINGAPORE, May 21, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("MaNaDr" or "the Company"), a leading Asia-Pacific telehealth provider, today announced that for the first... ► Artikel lesen | |
| 22.04.24 | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | 298 | GlobeNewswire (Europe) | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| 15.04.24 | Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange | 464 | GlobeNewswire (Europe) | SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its successful initial public offering... ► Artikel lesen | |
| 13.04.24 | Mobile-health Network Solutions Announces Closing of Initial Public Offering | 883 | GlobeNewswire (Europe) | SINGAPORE, April 12, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions ("MNDR" or "the Company"), a leading telehealth solutions provider in Singapore, today announced the closing of its previously... ► Artikel lesen | |
| 10.04.24 | Mobile-health Network Solutions Prices IPO Of 2.25 Mln Class A Shares At $4.00/shr | 909 | AFX News | WASHINGTON (dpa-AFX) - Mobile-health Network Solutions, a telehealth solutions provider in Singapore, said that it has priced its initial public offering of an aggregate 2.25 million Class A... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,102 | +4,07 % | Sernova Aktie: Positives Umsatzwachstum gemeldet! | Das Biotechnologieunternehmen erweitert sein Führungsteam, sichert Finanzierungen und erhält FDA-Freigabe für klinische Studien zur Behandlung von Hypothyreose. Sernova Biotherapeutics, ehemals Sernova... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,613 | -3,46 % | Q1 EPS Forecast for Atossa Therapeutics Boosted by Analyst | ||
| PING AN HEALTHCARE | 0,829 | -0,34 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,014 | -23,33 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,298 | +4,93 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results |
SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,914 | -1,61 % | Cytosorbents Corp: CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights | 2024 marked by strong commercial execution and improved operating leverage
Company continues to expect DrugSorb-ATR regulatory decisions from Health Canada and... ► Artikel lesen | |
| VERU | 0,606 | +33,66 % | Veru Aktie: Kreuzung ohne klare Richtung! | Die Veru-Aktie konnte im jüngsten Handel einen leichten Aufschwung verzeichnen. Am 22. März stieg der Kurs um 2,35% auf 0,48 EUR, was eine positive Entwicklung gegenüber dem Vortagsschluss darstellt.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,674 | -0,88 % | Tempest Therapeutics: Tempest Reports Year End 2024 Financial Results and Provides Business Update | • Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement... ► Artikel lesen | |
| VOLITIONRX | 0,590 | +13,14 % | VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Monday, March 31 at 4:30 p.m. U.S. Eastern Time HENDERSON, Nevada, March 31, 2025 /PRNewswire/ -- VolitionRx... ► Artikel lesen | |
| EKSO BIONICS | 0,395 | +2,33 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
| IMUNON | 0,940 | -2,59 % | Imunon, Inc.: IMUNON Finalizes Phase 3 Study Design with FDA for IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer | First and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in patients with advanced ovarian cancer Initiation of trial sites underway for ground-breaking Phase 3... ► Artikel lesen | |
| BEYOND AIR | 0,240 | -5,51 % | Beyond Air Aktie: Langfristige Strategien überarbeitet | Medizintechnikunternehmen verzeichnet Umsatzwachstum trotz Kursschwäche und erweitert internationale Präsenz durch neue Zulassungen in Europa und Australien Beyond Air verzeichnete im gestrigen Handel... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| AROVELLA THERAPEUTICS | 0,043 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Cancel - Proposed issue of securities - ALA | ||
| NOVACYT | 0,469 | +2,29 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights |
Das Unternehmen MOBILE-HEALTH NETWORK SOLUTIONS kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,040 (+2,14 %) liegt der Kurs bei 1,910 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MOBILE-HEALTH NETWORK SOLUTIONS finden Sie auf Wallstreet Online.
